Literature DB >> 9007451

Skeletal muscle buffering capacity and endurance performance after high-intensity interval training by well-trained cyclists.

A R Weston1, K H Myburgh, F H Lindsay, S C Dennis, T D Noakes, J A Hawley.   

Abstract

Skeletal muscle buffering capacity (beta m), enzyme activities and exercise performance were measured before and after 4 weeks of high-intensity, submaximal interval training (HIT) undertaken by six well-trained competitive cyclists [mean maximal oxygen consumption (VO2max) = 66.2 ml.kg-1.min-1]. HIT replaced a portion of habitual endurance training and consisted of six sessions, each of six to eight repetitions of 5 min duration at 80% of peak sustained power output (PPO) separated by 1 min of recovery. beta m increased from 206.6 (17.9) to 240.4 (34.1) mumol H+.g muscle dw-1.pH-1 after HIT (P = 0.05). PPO, time to fatigue at 150% PPO (TF150) and 40-km cycle time trial performance (TT40) all significantly improved after HIT (P < 0.05). In contrast, there was no change in the activity of either phosphofructokinase or citrate synthase. In addition, beta m correlated significantly with TT40 performance before HIT (r = -0.82, P < 0.05) and the relationship between change in beta m and change in TT40 was close to significance (r = -0.74). beta m did not correlate with TF150. These results indicate that beta m may be an important determinant of relatively short-duration (< 60 min) endurance cycling activity and responds positively to just six sessions of high-intensity, submaximal interval training.

Entities:  

Mesh:

Year:  1997        PMID: 9007451     DOI: 10.1007/s004210050119

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  58 in total

1.  Effects of endurance training on the isocapnic buffering and hypocapnic hyperventilation phases in professional cyclists.

Authors:  J L Chicharro; J Hoyos; A Lucía
Journal:  Br J Sports Med       Date:  2000-12       Impact factor: 13.800

Review 2.  Interval training for performance: a scientific and empirical practice. Special recommendations for middle- and long-distance running. Part II: anaerobic interval training.

Authors:  L V Billat
Journal:  Sports Med       Date:  2001-02       Impact factor: 11.136

Review 3.  The effect of endurance training on parameters of aerobic fitness.

Authors:  A M Jones; H Carter
Journal:  Sports Med       Date:  2000-06       Impact factor: 11.136

Review 4.  The scientific basis for high-intensity interval training: optimising training programmes and maximising performance in highly trained endurance athletes.

Authors:  Paul B Laursen; David G Jenkins
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 5.  Adaptations to training in endurance cyclists: implications for performance.

Authors:  J A Hawley; N K Stepto
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 6.  Physiology of professional road cycling.

Authors:  A Lucia; J Hoyos; J L Chicharro
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 7.  Training techniques to improve endurance exercise performances.

Authors:  Zuko N Kubukeli; Timothy D Noakes; Steven C Dennis
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

8.  Muscle buffer capacity and aerobic fitness are associated with repeated-sprint ability in women.

Authors:  David Bishop; Johann Edge; Carmel Goodman
Journal:  Eur J Appl Physiol       Date:  2004-08       Impact factor: 3.078

9.  Effects of 20-s and 180-s double poling interval training in cross-country skiers.

Authors:  Johnny E Nilsson; Hans-Christer Holmberg; Per Tveit; Jostein Hallén
Journal:  Eur J Appl Physiol       Date:  2004-03-13       Impact factor: 3.078

10.  Effects of beta-alanine supplementation and interval training on physiological determinants of severe exercise performance.

Authors:  Micah Gross; Chris Boesch; Christine S Bolliger; Barbara Norman; Thomas Gustafsson; Hans Hoppeler; Michael Vogt
Journal:  Eur J Appl Physiol       Date:  2013-11-09       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.